RhumbLine Advisers
CMAX

RhumbLine Advisers’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

RhumbLine Advisers’s Portfolio CMAX Stock Details CMAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,077
Closed -$5.79K – 4429
2024
Q2 		$5.79K Sell
2,077
-1,467
-41% -$4.58K ﹤0.01% 4061
2024
Q1 		$17.1K Buy
3,544
+125
+4% +$1.05K ﹤0.01% 3787
2023
Q4 		$51.1K Sell
3,419
-66
-2% -$2.74K ﹤0.01% 3628
2023
Q3 		$222K Sell
3,485
-190
-5% -$13.3K ﹤0.01% 3105
2023
Q2 		$343K Buy
3,675
+678
+23% +$59.7K ﹤0.01% 2927
2023
Q1 		$240K Buy
2,997
+137
+5% +$16K ﹤0.01% 2690
2022
Q4 		$313K Sell
2,860
-22
-0.8% -$3.29K ﹤0.01% 2664
2022
Q3 		$613K Buy
2,882
+161
+6% +$32.5K ﹤0.01% 2403
2022
Q2 		$296K Buy
+2,721
New +$467K ﹤0.01% 2762

Other funds holding CMAX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

RhumbLine Advisers's CMAX Position: Q3 2024 in Review

RhumbLine Advisers sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q3 2024, closing a stake of 2,077 shares — an estimated $5.79K sold.

RhumbLine Advisers first reported a position in CMAX in Q2 2022 and held it in 9 quarters. The position peaked at $613K in Q3 2022. 21 funds tracked by Wall St. Rank hold CMAX as of Q3 2024.

  • RhumbLine Advisers reported no remaining CareMax, Inc. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 2,077 CareMax, Inc. Class A Common Stock shares in Q3 2024, an estimated $5.79K.
  • RhumbLine Advisers first reported a position in CareMax, Inc. Class A Common Stock in Q2 2022 and held it in 9 quarters.
  • RhumbLine Advisers's CareMax, Inc. Class A Common Stock position peaked at $613K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.